About IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals is a company based in Mountain View (United States) founded in 1994.. IntraBiotics Pharmaceuticals has raised $40.4 million across 3 funding rounds from investors including Orbimed, International Bio Medical and New England Capital Partners. IntraBiotics Pharmaceuticals operates in a competitive market with competitors including AFYX Therapeutics, OraPharma, Marizyme, Acologix and AB-Biotics, among others.
- Headquarter Mountain View, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40.4 M (USD)
in 3 rounds
-
Latest Funding Round
$3.5 M (USD), Series B
Mar 01, 2003
-
Investors
Orbimed
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals has successfully raised a total of $40.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $3.5 million completed in March 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $3.5M
-
First Round
First Round
(04 Feb 1999)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2003 | Amount | Series B - IntraBiotics Pharmaceuticals | Valuation |
investors |
|
| Jan, 2002 | Amount | Series B - IntraBiotics Pharmaceuticals | Valuation |
investors |
|
| Feb, 1999 | Amount | Series B - IntraBiotics Pharmaceuticals | Valuation | International Bio Medical |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, International Bio Medical and New England Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
A private investment firm focused on acquiring operating companies.
|
Founded Year | Domain | Location | |
|
Portfolio of medical devices
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IntraBiotics Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IntraBiotics Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intrabiotics Pharmaceuticals Comparisons
Competitors of IntraBiotics Pharmaceuticals
IntraBiotics Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYX Therapeutics, OraPharma, Marizyme, Acologix and AB-Biotics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug patches for mucosal disease treatments are developed.
|
|
| domain | founded_year | HQ Location |
Oral health products for treatment and maintenance are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for chronic wounds, thrombolysis, and dental health are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics are developed for kidney and bone metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Probiotic drugs for dental disorders and nutraceuticals are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intrabiotics Pharmaceuticals
Frequently Asked Questions about IntraBiotics Pharmaceuticals
When was IntraBiotics Pharmaceuticals founded?
IntraBiotics Pharmaceuticals was founded in 1994 and raised its 1st funding round 5 years after it was founded.
Where is IntraBiotics Pharmaceuticals located?
IntraBiotics Pharmaceuticals is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Is IntraBiotics Pharmaceuticals a funded company?
IntraBiotics Pharmaceuticals is a funded company, having raised a total of $40.4M across 3 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Feb 04, 1999.
What does IntraBiotics Pharmaceuticals do?
IntraBiotics Pharmaceuticals was established in 1994 in Mountain View, United States, within the pharmaceuticals sector. Focus is placed on developing antibiotics to address oral mucositis in patients receiving radiotherapy for head-and-neck malignancies. The lead product, iseganan HCl, a synthetic peptide exhibiting broad-spectrum antimicrobial properties, is undergoing a pivotal Phase III clinical trial. Operations center on advancing treatments for radiotherapy-related complications.
Who are the top competitors of IntraBiotics Pharmaceuticals?
IntraBiotics Pharmaceuticals's top competitors include Marizyme, AFYX Therapeutics and AB-Biotics.
Who are IntraBiotics Pharmaceuticals's investors?
IntraBiotics Pharmaceuticals has 4 investors. Key investors include Orbimed, International Bio Medical, New England Capital Partners, and Kauffman Foundation.